REG - Seed Innovations Ltd - Appointment of Executive Director

Seed InnovationsAnnouncement

01/09/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230901:nRSA0318La&default-theme=true

RNS Number : 0318L  Seed Innovations Limited  01 September 2023

1 September 2023

 

SEED Innovations Limited

 

("SEED" or the "Company")

 

Appointment of Executive Director

 

SEED Innovations Ltd, the AIM-quoted company investment company providing
shareholders with exposure to early-stage health, wellness and medical
cannabis companies to which, in normal circumstances, they have limited access
to, is pleased to announce that it has strengthened its board with the
appointment of Mr. Alfredo Pascual as Executive Director, effective 1
September 2023.

Alfredo has held the position of Vice President of Investment Analysis at SEED
Innovations since April 2021. In his role at SEED to date, Alfredo has
leveraged his connections in the European cannabis industry sourcing new
investments and supporting existing portfolio companies in the space. Latterly
Alfredo has applied his analytical skills across all sectors of interest to
the Company, while also taking an increasingly pivotal role in the general
direction and management of the fund.

Ed McDermott, Chief Executive Officer, commented: "I am thrilled to extend a
warm welcome to Alfredo to our Board. Beyond his cannabis industry expertise,
Alfredo's analysis has proven extremely valuable  in the implementation of
our investment strategy. Alfredo is currently a Level III candidate in the CFA
Program, adding an extra layer of value to the board and shareholders alike as
we remain committed to our investment policy of disruptive growth
opportunities."

 

The information required by Rule 17 and paragraph (g) of Schedule 2 of the AIM
Rules for Companies in relation to the appointment of Mr. Alfredo Pascual
Romero (known as Mr Alfredo Pascual) (aged 36) is as follows:

Current directorships

Avextra AG (Supervisory Board)

 

Save as disclosed above, there are no further disclosures required to be made
in respect of the appointment of Mr. Alfredo Pascual under Schedule 2(g) or
Rule 17 of the AIM Rules for Companies.

This announcement contains inside information for the purposes of Article 7 of
Regulation (EU) 596/2014.

*ENDS*

For further information on the Company please visit:  www.seedinnovations.co
(http://www.seedinnovations.com/) or contact:

 

  Ed McDermott        SEED Innovations Ltd           E: info@seedinnovations.co

 Lance de Jersey
 James Biddle         Beaumont Cornish Limited,      T: (0)20 7628 3396

 Roland Cornish       Nomad
 Isabella Pierre      Shard Capital Partners LLP     T: (0)20 7186 9927

 Damon Heath          Broker
 Catherine Leftley    St Brides Partners Ltd,        E: info@stbridespartners.co.uk

 Ana Ribeiro          Financial PR

 Isabelle Morris

 

 

Notes

 

Seed Innovations Ltd

 

SEED Innovations is an AIM quoted investment company focused primarily on
disruptive high growth life sciences and technology businesses particularly
within the medical cannabis arena. The Company's strategy is to identify
early-stage opportunities that have an upcoming investment catalyst and grow
its portfolio in terms of value whilst limiting the number of investee
companies to a level where relevant time can be devoted to each.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAFLFFATIILVIV